Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements
Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2021-07-29. On CanQuery you can follow the original downloads. Files are available in English and French.
COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-29
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements (French, HTML) HTML · Download HTML
- Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements (English, HTML) HTML · Download HTML